Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon
NCT ID: NCT01711307
Last Updated: 2020-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
220 participants
INTERVENTIONAL
2012-10-01
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between Acute Analgesia and Long-Term Function Following Ankle Injuries
NCT02667730
Effect of Adductor Canal Block vs. Placebo on Muscle Strength, Mobilisation and Pain After Total Knee Arthroplasty
NCT02242591
Treatment of Early Phase Achilles Tendinopathy - the Effect of NSAIDs
NCT03401177
The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy
NCT00377910
Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures
NCT05037812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non-operative
cast applied within 48 hours
non-operative
casting within 48 hrs
operative
cast applied within 48 hours and surgery within 14 days
operative
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
operative
non-operative
casting within 48 hrs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Present for initial assessment and treatment with application of a plantar-flexed cast within 48 hours of their injury.
* Referred to one of the participating orthopaedics surgeons in a timely fashion so as to allow for further treatment (operative repair or initiation of the rehabilitation protocol) within 14 days of their injury.
Exclusion Criteria
* Achilles injury that is not a mid-substance tendon injury
* Any additional injury to the ipsilateral lower extremity
* Contraindication to surgery or anesthetic
* (Physical or mental) that may interfere with compliance with the rehabilitation protocol
* Any known factor for increased risk of Achilles tendon rupture (i.e. diabetes mellitus, immunosuppressive therapy including local or systemic steroids, and fluoroquinolone use).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Mark Glazebrook
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Glazebrook
Dr Mark Glazebrook, MSc,PHD, Dip Sports Med, MD FRCS(c)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Mark Glazebrook, MD
Role: PRINCIPAL_INVESTIGATOR
Capital Health District Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Halifax Infirmary
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.